Although there is extensive literature suggesting that estrogens play a role in the pathogenesis of breast cancer in BRCA1/2 mutation carriers, this study investigated the relationship between BMI and breast aromatase expression. This evidence concerns the gene CYP19A1 and breast carcinoma.